PURE PURE BIOSCIENCE, INC.
Miscellaneous Chemical Products · OTC · SEC CIK 1006028 · Fiscal year ends 07/31
Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.3%
TTM net income YoY-3.5%
TTM EPS YoY0.0%
Revenue 3-yr CAGR7.4%
Net income 3-yr CAGR—
Margins
Gross margin57.3%
Operating margin-90.0%
Net margin-107.3%
FCF margin—
EBITDA margin-89.8%
Returns
ROE—
ROA-220.6%
ROIC (approx.)—
Asset turnover2.06x
Leverage & solvency
Liabilities / assets636.4%
Debt / equity—
Current ratio0.27x
Interest coverage-5.12x
Cash quality & payout
Operating cash flow / net income0.70x
Accruals ratio-66.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q4*2026-07-31 | 2026Q32026-04-30 | 2026Q22026-01-31 | 2026Q12025-10-31 | 2025Q4*2025-07-31 | 2025Q32025-04-30 | 2025Q22025-01-31 | 2025Q12024-10-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $659,000 | $506,000 | $443,000 | $707,000 | $763,000 | $489,000 | $391,000 | $555,000 |
| Cost of revenue | $291,000 | $237,000 | $206,000 | $258,000 | $296,000 | $208,000 | $164,000 | $231,000 |
| Gross profit | $369,000 | $269,000 | $238,000 | $450,000 | $468,000 | $283,000 | $227,000 | $325,000 |
| R&D expense | $93,000 | $79,000 | $74,000 | $86,000 | $73,000 | $91,000 | $81,000 | $71,000 |
| SG&A expense | $779,000 | $708,000 | $847,000 | $743,000 | $731,000 | $776,000 | $871,000 | $881,000 |
| Operating income | -$503,000 | -$518,000 | -$683,000 | -$379,000 | -$336,000 | -$584,000 | -$725,000 | -$627,000 |
| Interest expense | $106,000 | $106,000 | $101,000 | $94,000 | $89,000 | $78,000 | $70,000 | $62,000 |
| Net income | -$610,000 | -$624,000 | -$785,000 | -$464,000 | -$332,000 | -$580,000 | -$798,000 | -$689,000 |
| EBITDA | -$502,000 | -$518,000 | -$682,000 | -$378,000 | -$336,000 | -$583,000 | — | — |
| EPS (basic) | — | -0.01 | -0.01 | 0.00 | — | -0.01 | -0.01 | -0.01 |
| EPS (diluted) | — | -0.01 | -0.01 | 0.00 | — | -0.01 | -0.01 | -0.01 |
| Weighted avg. shares (diluted) | — | 110.83M | 111.89M | 111.89M | — | 111.86M | 111.86M | 111.86M |
| Balance sheet | ||||||||
| Cash & equivalents | $569,000 | $983,000 | $198,000 | $434,000 | $334,000 | $540,000 | $202,000 | $346,000 |
| Receivables | $334,000 | $242,000 | $252,000 | $389,000 | $474,000 | $287,000 | $180,000 | $371,000 |
| Inventory | $193,000 | $232,000 | $244,000 | $237,000 | $141,000 | $131,000 | $75,000 | $72,000 |
| Current assets | $1.19M | $1.55M | $779,000 | $1.18M | $1.05M | $1.05M | $562,000 | $911,000 |
| PP&E, net | $8,000 | $9,000 | $9,000 | $10,000 | $11,000 | $11,000 | $12,000 | $13,000 |
| Total assets | $1.19M | $1.56M | $788,000 | $1.19M | $1.06M | $1.06M | $574,000 | $924,000 |
| Current liabilities | $4.37M | $3.65M | $3.06M | $3.16M | $2.11M | $972,000 | $866,000 | $911,000 |
| Long-term debt | $6.60M | — | — | — | — | — | — | — |
| Total debt | $6.60M | — | — | — | — | — | — | — |
| Total liabilities | $7.59M | $7.40M | $7.06M | $6.73M | $6.17M | $5.87M | $4.84M | $4.42M |
| Shareholders' equity | -$6.40M | -$5.84M | -$6.27M | -$5.55M | -$5.12M | -$4.81M | -$4.27M | -$3.50M |
| Net debt | $6.03M | — | — | — | — | — | — | — |
| Shares outstanding | 130.02M | 130.02M | 111.89M | 111.89M | 111.89M | 111.86M | 111.86M | 111.86M |
| Cash flow statement | ||||||||
| Operating cash flow | -$414,000 | -$468,000 | -$606,000 | -$250,000 | -$456,000 | -$512,000 | -$544,000 | -$503,000 |
| Financing cash flow | $0 | $1.25M | $370,000 | $350,000 | $250,000 | $850,000 | $400,000 | $500,000 |
| Depreciation & amortization | $1,000 | $0 | $1,000 | $1,000 | $0 | $1,000 | — | — |
| Stock-based compensation | $50,000 | $55,000 | $58,000 | $34,000 | $30,000 | $33,000 | $27,000 | $57,000 |
Free plan shows the latest 8 periods; Pro shows all 64 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.